MetaCap

Cabaletta Bio Statistics

NASDAQ: CABAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.9361-0.0739 (-7.32%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Cabaletta Bio by the numbers

Cabaletta Bio has a market capitalization of $201.9 million based on 215.72M shares outstanding. With trailing EPS of $-1.33, Cabaletta Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 45.8% below its 50-day average and 66.0% below its 200-day average.

Average daily trading volume is 5.15M shares, or about $4.8 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CABA valuation vs. peer median

CABA compared with the median of 8 peer companies
MetricCABAPeer medianDifference
Market cap$201.94M$203.41M-1%
Avg. volume5.15M775.98K+564%

Peer median across 8 companies: LCTX, IPSC, ARTV, ALLO, IKT, SCTX, CGEN, AUTL.

Valuation

Price and trading

Previous close
1.01
Open
0.99
Day range
0.93 – 1.03
52-week range
0.93 – 4.23
52-week change
-55.00%
Beta
—
Volume
3.73M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
201.94M
Forward Pe
-0.84
Eps
-1.33
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
4.23
Week52 Low
0.93
Avg Volume
5.15M
Shares Outstanding
215.72M
Ma50
1.73
Ma200
2.76
Earnings Date
Nov 5, 2026
Pct From52w High
-77.87%
Pct From52w Low
0.66%

Related